FDA Investigating Paclitaxel Coated Balloons and Eluting Stents

Prompted by a recent publication in the Journal of the American Heart Association that suggests a possible increased risk of death at two years and beyond in patients treated with vascular balloons coated with paclitaxel or stents that release paclitaxel, FDA said it is evaluating data and working directly with manufacturers to better understand this issue.


News & Features

QMed Supplier Categories